Streetbeat News

Stock Prices

CNTX

Maxim Group analyst Jason McCarthy has maintained a Buy rating on Context Therapeutics (NASDAQ:CNTX) and increased the price target from $4 to $10. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 5:10 pm

BENF

Trading of Beneficient Company (BENF) shares resumed after a temporary halt due to a circuit breaker trigger. The halt was implemented to manage volatility in the stock's price.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 5:09 pm

PZZA

Papa John's International, Inc. (NASDAQ:PZZA) reported a Q1 fiscal 2024 sales decline of 2.5% YoY to $513.92 million, missing consensus estimates. However, adjusted EPS of 67 cents beat expectations. North America and International comparable sales decreased by 2% and 3% respectively. The company saw 8 net unit openings, with global system-wide sales slightly down by 0.9% YoY. Adjusted operating income rose by 10% due to improved margins and cost discipline, despite a significant drop in net cash from operating activities and a small free cash outflow.

Portfolio Pulse from Akanksha Bakshi

May 09, 2024 | 5:05 pm

TOST

Over the last three months, 20 analysts have provided diverse opinions on Toast (NYSE:TOST), with recent updates showing a shift towards more positive ratings and higher price targets. The average 12-month price target has risen to $24.15, up 21.91% from the previous $19.81. Analysts from firms like Mizuho, Piper Sandler, and Goldman Sachs have adjusted their ratings and price targets, reflecting evolving market conditions and Toast's performance. Toast, a restaurant technology company, has shown notable revenue growth and processes a significant volume of transactions, despite its challenges in profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 5:01 pm

OSCR

Recent analyst evaluations of Oscar Health (NYSE:OSCR) show a mix of opinions, with 3 somewhat bullish and 1 indifferent rating in the last 30 days. The average 12-month price target for OSCR has been raised to $21.25, reflecting a 32.81% increase from the previous target of $16.00. Analysts from Wells Fargo, Goldman Sachs, and Raymond James have adjusted their ratings and price targets, indicating a positive outlook on the company's performance. Oscar Health's financials reveal a strong revenue growth rate of 45.8%, an impressive ROE of 19.32%, and an ROA of 4.42%, despite a net margin below industry averages and a smaller market capitalization.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 5:01 pm

DAL

LYV

SPLV

On CNBC's Halftime Report, analysts shared their final trades, highlighting Live Nation Entertainment (LYV), Delta Air Lines (DAL), and the Invesco S&P 500 Low Volatility ETF (SPLV). These picks suggest a focus on entertainment, travel, and low-volatility investment strategies.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 5:00 pm

LVLU

In the last three months, Lulus Fashion Lounge (NASDAQ:LVLU) received four indifferent analyst ratings, with a recent update showing an average 12-month price target of $2.69, indicating an 8.47% increase from the previous target. The company's financial performance shows a revenue decline of -17.59%, a net margin of -9.65%, an ROE of -11.5%, an ROA of -4.56%, and a debt-to-equity ratio of 0.64, suggesting challenges in revenue growth but efficient cost management and use of assets.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 5:00 pm

ETH-USD

Donald Trump's cryptocurrency portfolio experienced a significant increase of $1.3 million in a single day, reaching a total value of $6.581 million, following a pro-crypto speech. His portfolio includes MAGA, Ethereum, Wrapped Ethereum, BABYTRUMP, and Polygon tokens. Trump's speech, advocating for crypto donations to his campaign, has notably influenced the rally in election-related meme coins and highlighted the intersection of politics and cryptocurrency markets.

Portfolio Pulse from Murtuza Merchant

May 09, 2024 | 5:00 pm

CAKE

Raymond James analyst Brian Vaccaro upgrades Cheesecake Factory (NASDAQ:CAKE) from Market Perform to Outperform with a new price target of $42.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 4:56 pm

HGV

Hilton Grand Vacations Inc. (NYSE:HGV) reported a strong first-quarter FY24 performance with sales rising to $1.16 billion from $934 million a year ago, surpassing the consensus estimate of $1.12 billion. The company saw an increase in real estate sales and financing segment revenues to $687 million, and total contract sales grew by $108 million Y/Y to $631 million, including contributions from Bluegreen Vacations. Adjusted EBITDA and EPS both exceeded expectations, and the company continued its share repurchase program. HGV reiterated its FY24 guidance for Adjusted EBITDA and highlighted its focus on integrating Bluegreen Vacations and exploring new growth avenues.

Portfolio Pulse from Lekha Gupta

May 09, 2024 | 4:52 pm